Guixiong Zhang

No. 58 Zhongshan 2 Road
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Metastatic extramammary Paget's disease with divergent 18F-fluorodeoxyglucose/prostate-specific membrane antigen findings: a case of molecular misdirection.

Metastatic extramammary Paget's disease with divergent 18F-fluorodeoxyglucose/prostate-specific membrane antigen findings: a case of molecular misdirection.

Journal: Japanese journal of clinical oncology

Published: January 10, 2026

Efficacy and safety of TACE combined with lenvatinib and PD-1 Inhibitor in intermediate-stage HCC exceeding the up-7 criteria: a retrospective cohort study.

Efficacy and safety of TACE combined with lenvatinib and PD-1 Inhibitor in intermediate-stage HCC exceeding the up-7 criteria: a retrospective cohort study.

Journal: Frontiers in immunology

Published: January 14, 2025

Development and validation of nomogram including mutations in angiogenesis-related genes as risk factors for HCC patients treated with TACE.

Development and validation of nomogram including mutations in angiogenesis-related genes as risk factors for HCC patients treated with TACE.

Journal: Translational oncology

Published: December 10, 2024

Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.

Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.

Journal: Journal of translational medicine

Published: March 05, 2024

Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer.

Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer.

Journal: Frontiers in endocrinology

Published: October 14, 2022

Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism.

Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism.

Journal: Frontiers in oncology

Published: September 06, 2022

Identification and Validation of Novel Immunogenic Cell Death- and DNA Damage Response-Related Molecular Patterns Correlated with Immune Status and Prognosis in Hepatocellular Carcinoma.

Identification and Validation of Novel Immunogenic Cell Death- and DNA Damage Response-Related Molecular Patterns Correlated with Immune Status and Prognosis in Hepatocellular Carcinoma.

Journal: Translational oncology

Published: August 29, 2022

Dissecting a hypoxia-related angiogenic gene signature for predicting prognosis and immune status in hepatocellular carcinoma.

Dissecting a hypoxia-related angiogenic gene signature for predicting prognosis and immune status in hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: June 25, 2022

OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism.

OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism.

Journal: Frontiers in oncology

Published: June 24, 2022

Non-Apoptotic Programmed Cell Death-Related Gene Signature Correlates With Stemness and Immune Status and Predicts the Responsiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma.

Non-Apoptotic Programmed Cell Death-Related Gene Signature Correlates With Stemness and Immune Status and Predicts the Responsiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma.

Journal: Frontiers in cell and developmental biology

Published: January 18, 2022

Clinical Significance of Peripheral Blood Lymphocyte Subtypes and Cytokines in Patients with Hepatocellular Carcinoma Treated with TACE.

Clinical Significance of Peripheral Blood Lymphocyte Subtypes and Cytokines in Patients with Hepatocellular Carcinoma Treated with TACE.

Journal: Cancer management and research

Published: October 03, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026